期刊文献+

不同肝移植术式围手术期液体管理对术后肺部并发症发生的影响

Effects of perioperative fluid management on pulmonary complication in patients undergoing different liver transplantion procedures
原文传递
导出
摘要 目的评价不同经典原位肝移植术式及围手术期液体管理对术后肺部并发症发生的影响。方法回顾性分析南京军区福州总医院从2003年4月至2007年3月行经典原位肝移植手术的终末期肝病患者107例,单因素分析兼多因素Logistic回归分析患者术前(MELD评分,腹水状况,供肝冷缺血时间)、术中(手术方式,输液总量,晶体液体量,胶体液体量,输血液制品总量,白蛋白使用量,手术时间,无肝期时间)和术后(前3天每天的液体出入量)等情况与肝移植术后肺部并发症发生率的相关性。结果统计MELD评分≤15分和>15分且<25分病例,标准经典原位肝移植组和改良经典原位肝移植组的肺部并发症发生率有显著差异。改良经典原位肝移植组比标准经典原位肝移植组术中输液总量>10L的患者(P=0.020)和术后前3天至少有2天的液体平衡≤-300mL的患者均减少(P=0.023)。肝移植术中输液总量>10L(P=0.023)和输血液制品总量>4L(P=0.032)是术后发生肺部并发症的危险因素,而采用改良经典原位肝移植(P=0.006)和术后前3天至少有2天的液体平衡≤-300mL(P=0.040)则是保护因素。结论改良经典原位肝移植术和术后前3天至少有2天的液体平衡≤-300mL,能够显著降低术后的肺部并发症发生率。 Objective: To evaluate the effects of perioperative fluid therapy on pulmonary complication after standard classic liver transplantation and modified classic liver transplantation and the risk factors of the treatment. Method: A total of 107 patients receiving liver transplantation for end-stage liver disease between April 2003 and March 2007 were analyzed retrospectively in our hospital. We used mono-factorial and multivariate logistic regression analysis to investigate the relationship between pulmonary complication and the following variables: the pre-operative Meld score, ascites condition and cold ischemia time (CIT) of donor liver ; intraoperation-2 types of liver transplantation, total amount of the infusion, liquid volume of the crystal, liquid volume of the colloidal, total transfusion of blood products, the use of albumin, operation time, the time of anhepatic period; daily volume of net fluid retention in the first 3 days after surgery. We compared the standard classic liver transplantation group and the modified classic liver transplantation group. Results: Significant difference in pulmonary complication was found between the standard classic liver transplantation and the modified classic liver transplantation patients in the situation of Meld score ≤15 points and 15-25points. Compared to the patient with standard procedures, those with modified procedures had a reduced total amount of the intraoperative infusion (P=0.020) and larger number of patients whose fluid balance ≤-300 ml for no less than 2 days in the first 3 days after operation (P=0.023). The total amount of the intraoperative infusion>10L(P=0.023) and total intraoperative transfusion of blood products>4L(P=0.032) were the risk factors of pulmonary complication, while the modified classic liver transplantation(P=0.006)and fluid balance ≤ -300 ml for no less than 2 days in the first 3 days after operation were the protective factors. Conclusion: The modified classic liver transplantation and maintaining fluid balance at ≤-300 ml for no less than 2 days in the first 3 days after operation could significantly reduce the incidence of pulmonary complication after surgery.
出处 《中华移植杂志(电子版)》 CAS 2008年第1期4-9,共6页 Chinese Journal of Transplantation(Electronic Edition)
基金 全军十一五杰出人才基金资助课题(项目编号06J007)
关键词 肺部并发症 改良经典原位肝移植术 液体治疗 Pulmonary complication Modified classic liver transplantation Fluid therapy
  • 相关文献

参考文献14

  • 1Xiao-Hong Wen, Hai-Ying Kong, Sheng-Mei Zhu, Jian-Hong Xu, Su-Qin Huang and Qing-Lian Chen Hangzhou, China Department of Anesthesia, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Plasma levels of tumor necrotic factor-alpha and interleukin-6, -8 during orthotopic liver transplantation and their relations to postoperative pulmonary complications[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):38-41. 被引量:21
  • 2Daniela Kniepeiss,Florian Iberer,Barbara Grasser,Silvia Schaffellner,Vanessa Stadlbauer,Karl-Heinz Tscheliessnigg.A single-center experience with retrograde reperfusion in liver transplantation[J]. Transplant International . 2003 (10)
  • 3R. Golfieri,E. Giampalma,A. M. Morselli Labate,P. d’Arienzo,E. Jovine,G. L. Grazi,A. Mazziotti,M. Maffei,C. Muzzi,S. Tancioni,C. Sama,A. Cavallari,G. Gavelli.Pulmonary complications of liver transplantation: radiological appearance and statistical evaluation of risk factors in 300 cases[J]. European Radiology . 2000 (7)
  • 4Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease. Hepatology . 2001
  • 5Freeman RB Jr,Wiesner RH,Harper A,et al.The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transplantation . 2002
  • 6Mack C L,,Millis J M,Whitington P F,et al.Pulmonarycomplications following liver transplantation in pediatric patients. Pediatric Transplantation . 2000
  • 7Pulimood TB,Park GR.Debate: Albumin administration should be avoided in the critically ill. Crit Care . 2000
  • 8GRUTTADAURIA S,CINTORINO D,MUSUMECI A,et al.Comparison of two differenttechniques of reprfusion in adultortho-topic liver transplantation. Clinical Transplantation . 2006
  • 9Hong SK,Hwang S,Lee SG,et al.Pulmonary complications fol- lowing adult liver transplantation. Transplantation Proceedings . 2006
  • 10Webert KE,Blajchman MA.Transfusion-related acute lung injury. Curt Opin Hematol . 2005

二级参考文献25

  • 1Jaeschke H.Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning,2003(01).
  • 2Maruo N;Morita I;Shirao M.IL-6 increases endothelial permeability in vitro,1992(02).
  • 3Krowka MJ,Dickson ER,Wiesner RH,et al.A prospective study of pulmonary function and gas exchange following liver transplantation. Chest . 1992
  • 4Glanemann M,Kaisers U,Langrehr JM,et al.Incidence and indications for reintubation during postoperative care following orthotopic liver transplantation. Journal of Clinical Anesthesia . 2001
  • 5Wang LM,Tian XF,Song QY,et al.Expresion and role of inducible nitric oxide synthase in ischemic-reperfusion liver in rat. Journal of Hepatobiliary Pancreat Disease . 2003
  • 6Koo DJ,Chaudry IH,Wang P.Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. Journal of Surgical Research . 1999
  • 7Yagnik GP,Takahashi Y,Tsoulfas G,et al.Blockade of the Larginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology . 2002
  • 8Younossi ZM,Boparai N,Price LL,Kiwi ML,McCormick M,Guyatt G.Health-related quality of life in chronic liver di- sease : the impact of type and severity of disease. Am J Gastro- enterol . 2001
  • 9Hourani JM,Bellamy PE,Tashkin DP,Batra P,Simmons MS.Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. The American Journal of Medicine . 1991
  • 10Mohamed R,Freeman JW,Guest PJ,Davies MK,Neuberger JM.Pulmonary gas exchange abnormalities in liver transplant candidates. Liver Transplantation . 2002

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部